Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Frederic Colombel

Showing results (251-260 of 462) with videos related to

Pageof 47
Sort By:
Gut|August 27, 2013
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trialLaurent Peyrin-Biroulet, Walter Reinisch, Jean-Frederic Colombel, et al.
Gastroenterology|November 9, 2011
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitisWilliam J Sandborn, Gert van Assche, Walter Reinisch, et al.
Journal of Crohn'S & Colitis|January 5, 2018
Magnetic Resonance Imaging Predicts Histopathological Composition of Ileal Crohn's DiseaseMathilde Wagner, Huaibin Mabel Ko, Manjil Chatterji, et al.
Journal of Crohn'S & Colitis|December 28, 2016
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional TherapyGeert D'Haens, Walter Reinisch, Jean-Frederic Colombel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2020
Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative ColitisJean-Frederic Colombel, Mark T Osterman, Andrew J Thorpe, et al.
Gastroenterology|November 28, 2017
Interactions Between Diet and the Intestinal Microbiota Alter Intestinal Permeability and Colitis Severity in MiceSean R Llewellyn, Graham J Britton, Eduardo J Contijoch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 15, 2024
Prevalence and Prognosis of Mild Inflammatory Bowel Disease: A Population-based Cohort Study, 1997-2020Henrik Albaek Jacobsen, Anastasia Karachalia-Sandri, Anthony C Ebert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 15, 2026
Histopathologic evaluation and reporting in inflammatory bowel disease A consensus paper sponsored by the Rodger C. Haggitt Gastrointestinal Pathology SocietyAlexandros D Polydorides, Xiuli Liu, Shaomin Hu, et al.
Inflammatory Bowel Diseases|February 18, 2026
Artificial intelligence enhances screening efficiency for inflammatory bowel disease clinical trials: a prospective studyAkshita Gupta, Ryan C Ungaro, Adam Steinlauf, et al.
Lancet (London, England)|June 6, 2002
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialStephen B Hanauer, Brian G Feagan, Gary R Lichtenstein, et al.
Pageof 47

Showing results (251-260 of 462) with videos related to

Sort By:
Pageof 47
Gut|August 27, 2013
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trialLaurent Peyrin-Biroulet, Walter Reinisch, Jean-Frederic Colombel, et al.
Gastroenterology|November 9, 2011
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitisWilliam J Sandborn, Gert van Assche, Walter Reinisch, et al.
Journal of Crohn'S & Colitis|January 5, 2018
Magnetic Resonance Imaging Predicts Histopathological Composition of Ileal Crohn's DiseaseMathilde Wagner, Huaibin Mabel Ko, Manjil Chatterji, et al.
Journal of Crohn'S & Colitis|December 28, 2016
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional TherapyGeert D'Haens, Walter Reinisch, Jean-Frederic Colombel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2020
Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative ColitisJean-Frederic Colombel, Mark T Osterman, Andrew J Thorpe, et al.
Gastroenterology|November 28, 2017
Interactions Between Diet and the Intestinal Microbiota Alter Intestinal Permeability and Colitis Severity in MiceSean R Llewellyn, Graham J Britton, Eduardo J Contijoch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 15, 2024
Prevalence and Prognosis of Mild Inflammatory Bowel Disease: A Population-based Cohort Study, 1997-2020Henrik Albaek Jacobsen, Anastasia Karachalia-Sandri, Anthony C Ebert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 15, 2026
Histopathologic evaluation and reporting in inflammatory bowel disease A consensus paper sponsored by the Rodger C. Haggitt Gastrointestinal Pathology SocietyAlexandros D Polydorides, Xiuli Liu, Shaomin Hu, et al.
Inflammatory Bowel Diseases|February 18, 2026
Artificial intelligence enhances screening efficiency for inflammatory bowel disease clinical trials: a prospective studyAkshita Gupta, Ryan C Ungaro, Adam Steinlauf, et al.
Lancet (London, England)|June 6, 2002
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialStephen B Hanauer, Brian G Feagan, Gary R Lichtenstein, et al.
Pageof 47